Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation

American Journal of Transplantation

Volumn 3, Issue 10, 2003, Pages 1278-1288

  Rogers, Jeffrey ^a   Baliga, Prabhakar K ^a   Chavin, Kenneth D ^a   Lin, Angello ^a   Emovon, Osemwegie ^a   Afzal, Fuad ^a   Baillie, G Mark ^a,b   Ashcraft, Elizabeth E ^a,b   Rajagopalan, P R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

African American; Ethnicity; Kidney; Pancreas; Transplantation

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CAUCASIAN; CAUSE OF DEATH; COMORBIDITY; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEGRO; ORGAN PRESERVATION; OUTCOMES RESEARCH; PANCREAS TRANSPLANTATION; POSTOPERATIVE INFECTION; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT INDICATION;

ADULT; AFRICAN AMERICANS; BIOPSY; BLOOD GLUCOSE; CREATININE; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0141669246     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00208.x     Document Type: Article

References (53)

1. Adang EMM, Engel GL, Van Hooff JP, Koostra G. Comparison before and after transplantation of pancreas-kidney and pancreas-kidney with loss of pancreas-a prospective controlled quality of life study. Transplantation 1996; 62: 754-758
2. Esmatjes E, Ricart MJ, Fernandez-Cruz L, Gonzaleaz-Clemente JM, Saenz A, Astudillo E. Quality of life after successful pancreas-kidney transplantation. Clin Transplant 1994; 8: 75.
3. Najarian AJ, McHugh L, Payne W et al. Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. Clin Transplant 1998; 12: 233-242.
4. Esmatjes E, Adan A, Ricart MJ, Oppenheimer F et al. Long-term evolution of diabetic retinopathy and renal function after pancreas transplantation. Transplant Proc 1992; 24: 12.
5. Wang Q, Klein R, Moss SE et al. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy: a case series. Ophthalmology 1994; 101: 1071.
6. Allen RDM, Al-Harbi IS, Morris JGL et al. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation, 1997; 63: 830-838.
7. Navarro X, Sutherland DER, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol, 1997; 42: 727-736.
8. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75.
9. Wilczek HE, Jaremko G, Tyden G, Groth CG. Evolution diabetic nephropathy in kidney grafts: evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation 1995; 59: 51.
10. Hathaway DK, Abell T, Cardoso S, Hartwig MS, Gebely SE, Gaber AO. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. N Engl J Med 1994; 57: 816.
11. Jukema JW, Smets YFC, Van Der Pijl JW et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002; 25: 906-911.
12. Becker BN, Brazy PC, Becker YT et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000; 57: 2129.
13. Reddy KS, Stablein D, Taranto S et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alon in patients with type 1 diabetes mellitus and renal failure. Am J Kid Dis 2003; 41 (2): 464-470.
14. Issacs R, Lobo PI, Nock SL, Hanson JA, Ojo AO, Pruett TL. Racial disparities in acces to simultaneous pancreas-kidney transplantation. Am J Kid Dis 2000; 36: 525-533.
15. Zhou YC, Cecka JM, Terasaki PI. Effect of Race on Kidney Transplants. In:Terasaki PI., eds. Clinical Transplants, 1990. Los Angeles: UCLA Tissue Typing Laboratory, 1991: 447-459.
16. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan B. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. N Engl J Med 1991; 51: 338.
17. Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. N Engl J Med 1994; 57: 1064.
18. Katznelson S, Gjertson DW, Cecka JM. The effect of race and ethnicity on kidney allograft outcome. In: Cecka JM, Terasaki PI., eds. Clinical Transplants, 1995. Los Angeles: UCLA Tissue Typing Laboratory, 1996: 379-394.
19. Georgi B, Sumrani N, Murasky V et al. Racial differences in long-term renal allograft outcome. Transplant Proc 1996; 28: 1623.
20. Held PJ, Pauly M, Bovbjberg R, Newmann J, Salvatierra O. Access to kidney transplantation: Has the United States eliminated income and racial differences. Arch Int Med 1988; 148: 259-261.
21. Sanfilippo FP, Vaughn WK, Peters TG. Factors affecting waiting time of cadaveric kidney transplant candidates in the United States. JAMA 1992; 267: 247-252.
22. Ozminkowski RJ, Friedman BE, Taylor Z. Access to heart and liver transplantation in the late 1980s. Med Care 1993; 31: 1027-1042.
23. Eggers PW. Racial differences in access to kidney transplantation. Health Care Financing Rev 1995; 17: 17-89.
24. Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 1998; 280: 1140-1152.
25. 2000 U.S. Census Bureau, Population Division. Census December 2000.
26. Douzdjian V, Thacker LR, Blanton JW. Effect of race on outcome following kidney - pancreas transplantation in type I diabetics: The South - Eastern Organ Procurement Foundation experience. Clin N Engl J Med 1997; 11: 470.
27. Light JA, Sasaki TM, Currier CB, Barhyte DY. Successful long-term kidney-pancreas transplants regardless of c-peptide status or race. N Engl J Med 2001; 71: 152.
28. Sutherland DER, Moudry-Munns KC, Gruessner A. Pancreas transplant results in United Network for Organ Sharing (UNOS) United Stated of America (USA) registry with a comparison to non-USA data in the international registry. In: Terasaki PI, Cecka JM., eds. Clinical Transplants, 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 47-69.
29. Lo A, Stratta RJ, Egidi MF et al. Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. Transplant Proc 2001; 33: 1675,
30. Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. N Engl J Med 1998; 65: 515-523.
31. Odorico JS, Sollinger HW. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World J Surg 2002; 26: 194-211.
32. Stratta RJ. Mortality after vascularized pancreas transplantation. Surgery 1998; 124: 823-830.
33. Gruessner AC, Sutherland DER. Pancreas transplants for United States and non-US cases as reported to the international pancreas transplant registry and to the United Network for Organ Sharing. In: Cecka JM, Terasaki PI, eds. Clinical Transplants, 1997. Los Angeles: UCLA Tissue Typing Laboratory, 1998: 45-59.
34. Keil JE, Loadholt CB, Weinrich MC, Sandifer SH, Boyle E Jr. Incidence of coronary heart disease in blacks in Charleston, South Carolina. Am Heart J 1984; 108: 779-786.
35. Reddy KS, Stratta RJ, Shokouh-Amiri H et al. Simultaneous kidney-pancreas transplantation without antilymphocyte induction. N Engl J Med 2000; 69: 49.
36. Kaufman DB, Leventhal JR, Koffron A et al. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to no induction therapy with enteric drainage. Surgery 2000; 128: 726.
37. Gaston RS, Hudson SL, Deierhoi MH et al. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. N Engl J Med 1992; 53: 103-109.
38. Neylan JF. Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. N Engl J Med 1997; 64: 1277-1282.
39. International Pancreas Transplant Registry. 1999 Annual Report.
40. Klassen DK, Weir MR, Schweitzer EJ, Bartlett ST. Isolated pancreas rejection in combined kidney-pancreas transplantation: results of percutaneous pancreas biopsy. Transplant Proc 1995; 27: 1333-1334.
41. Shapiro R, Jordan ML, Scantlebury VP et al. Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist? N Engl J Med 2000; 69: 440-441.
42. Hawthorne WJ, Allen RDM, Greenberg ML et al. Simultaneous pancreas and kidney transplant rejection: separate or synchronous events? N Engl J Med 1997; 63: 352-358.
43. Cheung AH, Sutherland DER, Gillingham KJ et al. Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients. Kidney Int 1992; 41: 924-929.
44. Sollinger HW, Knechtle SJ, Reed A et al, Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. Ann Surg 1991; 214: 703-711.
45. Remuzzi G, Ruggenenti P, Mauer SM. Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet 1994; 343: 27-31.
46. Papadimitriou JC, Drachenberg CB, Wiland A et al. Histologic grading of acute allograft rejection in pancreas needle biopsy: correlation to serum enzymes, glycemia, and response to immunosuppressive treatment. N Engl J Med 1998; 66: 1741-1745.
47. El-Ghoroury M, Hariharan S, Munda R et al. Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients. Transplant Proc 1995; 27: 3133-3134.
48. Rajagopalan PR, Rogers J, Chavin KD et al. Cadaveric Renal North England Journal of Medicine in African-Americans in South Carolina. In: Cecka JM, Terasaki PI., eds. Clinical Transplants, 2001. Los Angeles: UCLA Immunogenetics Center, 2002: 45-59.
49. Kamath S, Dean D, Peddi VR et al. Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection. N Engl J Med 1997; 64: 1428-1432.
50. Walker JA, Klassen DK, Hooper FJ et al. Late pancreas allograft rejection: preliminary experience with factors predisposing to rejection. N Engl J Med 1996; 62: 539-543.
51. Gruessner RW, Bartlett ST, Burke GW, Stock PG. Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. Clin Transplant 1998; 12: 260-262.
52. Stratta RJ, Egidi MF, Corry RJ et al. Simultaneous use of FK506 and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. Transplant Proc 1997; 29: 654.
53. Jordan ML, Shapiro R, Gritsch HA et al. Long-term results of pancreas transplantation under tacrolimus immunosuppression. N Engl J Med 1999; 67: 266.